Busse, A., Alsdorf, W., Yeku, O. O., Taylor, S. E., Araujo, D. M., Jaeger, D., Wetzko, K., Jazaeri, A. A., Srour, S. A., Wermke, M., Mustea, A., Vollmer, F., Hilf, N., Chorna, N., Britten, C. M., Holderried, T. A. W. (2026). Phase 1a study results for IMA203CD8, a PRAME-directed T-cell receptor (TCR) T-cell therapy, in ovarian cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5509